Unbound MEDLINE

Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. The Journal of infectious diseases. [J Infect Dis] Journal article

 
TitleAntibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate.
Author(s)Davies HD, Adair C, McGeer A, Ma D, Robertson S, Mucenski M, Kowalsky L, Tyrell G, Baker CJ 
InstitutionDepartments of Microbiology and Infectious Disease, Pediatrics, and Community Health Sciences and Child Health Research Unit, Alberta Children's Hospital, University of Calgary, Calgary,T2T-5C7, Canada. dele.davies@crha-health.ab.ca
SourceJ Infect Dis 2001 Aug 1; 184(3):285-91.
MeSHAdult
Alberta
Antibodies, Bacterial
Canada
Cohort Studies
Comparative Study
Disease Transmission, Vertical
Female
Humans
Immunoglobulin G
Infant, Newborn
Parity
Polysaccharides, Bacterial
Population Surveillance
Pregnancy
Pregnancy Complications, Infectious
Rectum
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Serotyping
Streptococcal Infections
Streptococcus agalactiae
Vagina
AbstractIn a cohort study of 1207 pregnant women in Alberta, Canada, the serotype distributions of vaginal-rectal group B Streptococcus (GBS) isolates were compared with all isolates from neonates with invasive GBS disease identified by population-based surveillance. Serum concentrations of Ia, Ib, II, III, and V capsular polysaccharide (CPS)-specific IgG also were determined, according to serotype of the vaginal-rectal colonizing GBS strain. GBS colonization was detected in 19.5% (235 of 1207) of women. Serotype III accounted for 20.6% (48 of 233) of colonizing strains available for typing but for 37% (27 of 73) of invasive isolates from neonates (P<.01). Maternal colonization with type III was least likely to be associated with moderate concentrations of III CPS-specific IgG. Serotype III GBS is more invasive than other serotypes in this population; this may be due, at least in part, to poor maternal type III CPS-specific antibody response.
Languageeng
Pub Type(s)Journal Article
Multicenter Study
PubMed ID11443553
  
Advertise on this site.